Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes

International Immunology

Volumn 25, Issue 5, 2013, Pages 279-285

  Morandi, Fabio ^a   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

CD4+ T lymphocytes; HLA G; MicroRNA

Indexed keywords

CXCL16 CHEMOKINE; HLA G ANTIGEN; HMG BOX TRANSCRIPTION FACTOR 1; MICRORNA; MICRORNA 210; MIRNA 451; ODD SKIPPED RELATED 1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME 11; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MODULATION; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HLA-G ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MICRORNAS; SOLUBILITY;

EID: 84876815495     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs108     Document Type: Article

References (29)

1. Rouas-Freiss, N., Khalil-Daher, I., Riteau, B. et al. 1999. The immunotolerance role of HLA-G. Semin. Cancer Biol. 9:3.
2. Fainardi, E., Castellazzi, M., Stignani, M. et al. 2011. Emerging topics and new perspectives on HLA-G. Cell. Mol. Life Sci. 68:433.
3. Pistoia, V., Morandi, F., Wang, X. and Ferrone, S. 2007. Soluble HLA-G: Are they clinically relevant? Semin. Cancer Biol. 17:469.
4. Fujii, T., Ishitani, A. and Geraghty, D. E. 1994. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153:5516.
5. Fons, P., Chabot, S., Cartwright, J. E. et al. 2006. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108:2608.
6. Faure, M. and Long, E. O. 2002. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168:6208.
7. Fournel, S., Aguerre-Girr, M., Huc, X. et al. 2000. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol. 164:6100.
8. Bainbridge, D. R., Ellis, S. A. and Sargent, I. L. 2000. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol. 48:17.
9. Le Gal, F. A., Riteau, B., Sedlik, C. et al. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11:1351.
10. Gros, F., Cabillic, F., Toutirais, O., Maux, A. L., Sebti, Y. and Amiot, L. 2008. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur. J. Immunol. 38:742.
11. Morandi, F., Ferretti, E., Bocca, P., Prigione, I., Raffaghello, L. and Pistoia, V. 2010. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS ONE 5:e11763.
12. Morandi, F., Ferretti, E., Castriconi, R. et al. 2011. Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. Blood 118:5840.
13. Kanai, T., Fujii, T., Unno, N. et al. 2001. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am. J. Reprod. Immunol. 45:94.
14. Bahri, R., Hirsch, F., Josse, A. et al. 2006. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J. Immunol. 176:1331.
15. Mitsdoerffer, M., Schreiner, B., Kieseier, B. C. et al. 2005. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J. Neuroimmunol. 159:155.
16. Pasquinelli, A. E. 2012. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13:271.
17. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A. and Baltimore, D. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10:111.
18. Ghisi, M., Corradin, A., Basso, K. et al. 2011. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 117:7053.
19. Rouas, R., Fayyad-Kazan, H., El Zein, N. et al. 2009. Human natural Treg microRNA signature: role of microRNA-31 and micro-RNA-21 in FOXP3 expression. Eur. J. Immunol. 39:1608.
20. Ma, F., Xu, S., Liu, X. et al. 2011. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 12:861.
21. Jiang, S., Li, C., Olive, V. et al. 2011. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118:5487.
22. Guenin-Macé, L., Carrette, F., Asperti-Boursin, F. et al. 2011. Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc. Natl. Acad. Sci. U.S.A. 108:12833.
23. Lu, T. X., Hartner, J., Lim, E. J. et al. 2011. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFNgamma pathway, Th1 polarization, and the severity of delayedtype hypersensitivity. J. Immunol. 187:3362.
24. + T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184:6773.
25. Kanai, T., Fujii, T., Kozuma, S. et al. 2001. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol. Hum. Reprod. 7:195.
26. Morandi, F., Levreri, I., Bocca, P. et al. 2007. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res. 67:6433.
27. Cardili, R. N., Alves, T. G., Freitas, J. C. et al. 2010. Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis. Br. J. Dermatol. 163:769.
28. Bitarte, N., Bandres, E., Boni, V. et al. 2011. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29:1661.
29. Livingston, D. M. 2004. EMSY, a BRCA-2 partner in crime. Nat. Med. 10:127.